Daphne Koller (https://scl.ai/3lGnVFi), shares how recent advances in machine learning and medicine enable us to 'rethink' drug discovery and reverse a long-standing trend of declining drug research effectiveness.

Full discussion transcript - https://scl.ai/3lGnVFi

Bio: Daphne Koller is CEO and Founder of insitro, a machine-learning enabled drug discovery company. Daphne is also co-founder of Engageli, was the Rajeev Motwani Professor of Computer Science at Stanford University, where she served on the faculty for 18 years, the co-CEO and President of Coursera, and the Chief Computing Officer of Calico, an Alphabet company in the healthcare space.


Join the leading AI community full of leaders, visionaries, practitioners, and researchers. Get full access to more discussions like this: https://exchange.scale.com